SCHEMBL796265

SCHEMBL796265

COc1ccc(-c2nc3ccc(O)cc3s2)cc1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.74
KDM4E B2RXH2 2/20 0.74
ALDH1A1 P00352 2/20 0.74
HPGD P15428 2/20 0.74
SMN1; SMN2 Q16637 2/20 0.74
MEN1 O00255 1/20 0.74
NPC1 O15118 1/20 0.74
HCRTR1 O43613 1/20 0.74
TP53 P04637 1/20 0.74
MAPK1 P28482 1/20 0.74
BLM P54132 1/20 0.74
KMT2A Q03164 1/20 0.74
NPSR1 Q6W5P4 1/20 0.74
HSD17B10 Q99714 1/20 0.74
SULT1A1 P50225 4/20 0.69
GLA P06280 1/20 0.59
GAA P10253 1/20 0.59
PPARG P37231 1/20 0.59
RAB9A P51151 1/20 0.59
NCOA2 Q15596 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30884120 0.88 KDM4E (0.72) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL29217751 0.88 KDM4E (0.72) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL30504076 0.85 SMN1; SMN2 (1.00) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL2247388 0.85 SMN1; SMN2 (1.00) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL796269 0.81 APP (0.55) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL5423269 0.79 APP (0.81) MAPTKDM4EALDH1A1SMN1; SMN2NPC1
SCHEMBL12470894 0.79 KDM4E (0.70) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL4803017 0.79 AHR (0.79) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL2922465 0.77 APP (0.72) MAPTKDM4ESMN1; SMN2NPC1TP53
SCHEMBL10032122 0.76 APP (0.75) MAPTSMN1; SMN2TP53SULT1A1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides TECHNISCHE UNIVERSITAT MUNCHEN (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120070374-A1 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides IAPP, APP, HTT MAPT 10/4885KDM4E 4716/4885ALDH1A1 4488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.